# CDH13 文献サマリ（自動生成）

## 概要

- 検索クエリ: `NT5E[Title/Abstract] OR CD73[Title/Abstract]`
- 期間: 2015-01-01 〜 2025-11-30
- 取得件数 (PubMed): 50

## 文献一覧

| # | 年 | PMID | タイトル | ジャーナル |
|---|----|------|----------|------------|
| 1 | 2021 | 34429546 | Insulin signaling establishes a developmental trajectory of adipose regulatory T cells. | Nature immunology |
| 2 | 2021 | 33463071 | CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling. | Clinical and translational medicine |
| 3 | 2020 | 32024555 | CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. | Journal of hematology & oncology |
| 4 | 2024 | 38530357 | Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers. | The Journal of clinical investigation |
| 5 | 2024 | 39423241 | CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6. | Proceedings of the National Academy of Sciences of the United States of America |
| 6 | 2021 | 34253638 | Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer. | Journal for immunotherapy of cancer |
| 7 | 2018 | 29720980 | Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E. | Frontiers in immunology |
| 8 | 2023 | 36409930 | CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer. | Cancer immunology research |
| 9 | 2023 | 37620936 | 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells. | Journal of biomedical science |
| 10 | 2024 | 39430133 | CD73 alleviates osteoarthritis by maintaining anabolism and suppressing catabolism of chondrocytes extracellular matrix. | Journal of orthopaedic translation |
| 11 | 2025 | 40229283 | MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer. | Nature communications |
| 12 | 2020 | 32777746 | Targeting CD73 to augment cancer immunotherapy. | Current opinion in pharmacology |
| 13 | 2023 | 36719675 | ENPP1 Immunobiology as a Therapeutic Target. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| 14 | 2023 | 37409119 | Novel microRNAs modulating ecto-5'-nucleotidase expression. | Frontiers in immunology |
| 15 | 2024 | 39624281 | Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment. | Heliyon |
| 16 | 2023 | 36958430 | CD73 in glioblastoma: Where are we now and what are the future directions? | Immunology letters |
| 17 | 2023 | 36982618 | CD73: Friend or Foe in Lung Injury. | International journal of molecular sciences |
| 18 | 2023 | 37033953 | Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer. | Frontiers in immunology |
| 19 | 2024 | 39735551 | CD73: agent development potential and its application in diabetes and atherosclerosis. | Frontiers in immunology |
| 20 | 2023 | 36563135 | CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. | Advanced science (Weinheim, Baden-Wurttemberg, Germany) |
| 21 | 2019 | 31404305 | Generation and Function of Non-cell-bound CD73 in Inflammation. | Frontiers in immunology |
| 22 | 2023 | 37291128 | Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner. | Nature communications |
| 23 | 2025 | 40166277 | Tracing LYVE1(+) peritoneal fluid macrophages unveils two paths to resident macrophage repopulation with differing reliance on monocytes. | bioRxiv : the preprint server for biology |
| 24 | 2019 | 31461341 | Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73). | American journal of physiology. Cell physiology |
| 25 | 2016 | 26808918 | CD73-adenosine: a next-generation target in immuno-oncology. | Immunotherapy |
| 26 | 2021 | 33430239 | CD73, Tumor Plasticity and Immune Evasion in Solid Cancers. | Cancers |
| 27 | 2022 | 36946270 | Sarcoma - correlation between CD73 and PD-L1 and their relationship with prognosis. | Polish journal of pathology : official journal of the Polish Society of Pathologists |
| 28 | 2025 | 40582491 | Multi-omics analysis of polyamine metabolism implicates NT5E/CD73 in the progression of pancreatic cancer. | Cancer letters |
| 29 | 2025 | 41188606 | CD39 and CD73: biological functions, diseases and therapy. | Molecular biomedicine |
| 30 | 2023 | 37122331 | CD73, a significant protein in liver diseases. | Frontiers in medicine |
| 31 | 2022 | 35405741 | Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity. | Molecular cancer therapeutics |
| 32 | 2023 | 37511518 | The Clinical Significance of CD73 in Cancer. | International journal of molecular sciences |
| 33 | 2024 | 38392293 | The Purinergic Nature of Pseudoxanthoma Elasticum. | Biology |
| 34 | 2023 | 34773529 | Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance. | Cell biology and toxicology |
| 35 | 2022 | 35804900 | CD73 Promotes Chronic Lymphocytic Leukemia. | Cancers |
| 36 | 2021 | 33460629 | Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut. | Biochemical pharmacology |
| 37 | 2025 | 41284170 | Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints. | Discover oncology |
| 38 | 2024 | 38206570 | Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models. | Cancer biology & therapy |
| 39 | 2022 | 35779713 | The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer. | Seminars in cancer biology |
| 40 | 2018 | 29345574 | Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target. | Current medicinal chemistry |
| 41 | 2023 | 36503240 | Ecto-5'-nucleotidase (Nt5e/CD73)-mediated adenosine signaling attenuates TGFβ-2 induced elastin and cellular contraction. | American journal of physiology. Cell physiology |
| 42 | 2022 | 35813221 | CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway. | BioMed research international |
| 43 | 2023 | 37014046 | CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer. | Cancer research |
| 44 | 2020 | 32755765 | Adenosine and adenosine receptors in colorectal cancer. | International immunopharmacology |
| 45 | 2020 | 32351498 | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. | Frontiers in immunology |
| 46 | 2019 | 31024543 | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. | Frontiers in immunology |
| 47 | 2022 | 35711418 | The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells. | Frontiers in immunology |
| 48 | 2024 | 39354726 | Spatially restricted ecto-5'-nucleotidase expression promotes the growth of uterine leiomyomas by modulating Akt activity. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology |
| 49 | 2019 | 30556751 | CD73 as a potential opportunity for cancer immunotherapy. | Expert opinion on therapeutic targets |
| 50 | 2024 | 38227654 | CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway. | Proceedings of the National Academy of Sciences of the United States of America |
